A Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast Cancer

Mise à jour : Il y a 4 ans
Référence : NCT00371254

Femme Homme

Extrait

This study will determine whether the investigational drug dasatinib is effective in treatment of women with progressive advanced triple-negative breast cancer.


Critère d'inclusion

  • Breast Cancer ,Metastasis


Liens